Resources
Explore Our Research and Our Studies Portfolio
Nor Consult, LLC manages studies ranging from retrospective chart reviews to global, double-blinded Phase 3 RCTs. We provide services to emerging biotechs, established pharmaceutical companies and medical device manufacturers. We also support patient advocacy groups, universities and medical centers with executing grant-funded research projects.
More information about a selected number of studies that we have been involved with may be found by visiting the links below:
Proven Success in Action
Real-world success stories highlighting how Nor Consult supports sponsors with trial design, execution, and regulatory approval.
Confidential Cardiovascular and Cardiorenal Partnership
We are proud to partner with a leading clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative therapies for cardiovascular and kidney diseases. Our collaboration focuses on advancing novel treatments that target abnormally elevated aldosterone, a key driver in these conditions. Through our expertise in cardiovascular biometrics, we are helping them to bring forward a promising new approach to improve patient outcomes in hypertension and other related disorders.
i-FACTOR P-15
Nor Consult served as the Contract Research Organization (CRO) for Cerapedics’ P-15 clinical program in the 2010s, overseeing end-to-end execution for this complex, multi-center musculoskeletal trial. We coordinated protocol development, site initiation, clinical monitoring, data management, biostatistics, and regulatory submissions to maintain rigor and momentum from first patient into database lock. Our team integrated real-time data insights with proactive issue resolution to protect patient safety, uphold protocol integrity, and keep milestones on track. With vendor orchestration, inspection-ready documentation, and transparent governance, Nor Consult enabled our client to receive a PMA for their novel ortho biologic intervention.
Riluzole in Spinal Cord Injury (RISCIS)
Nor Consult served as the Contract Research Organization (CRO) for the RISCIS clinical trial, delivering end-to-end operational leadership across study design, IP supply, blinding, site activation, monitoring, data management, and regulatory compliance. We ensured global safeguarding of patient safety and protocol integrity across dozens of participating Level 1 trauma centers. From vendor orchestration to inspection readiness, our team provided transparent governance, audit-ready documentation, and decisive issue resolution—empowering our client, the AO Foundation, and the investigators to execute with confidence.
Global Contributions to Science
Peer-reviewed manuscripts and abstracts in leading journals including NEJM, JAMA, and The Lancet.
-
Featured in Leading JournalsPublished in NEJM, JAMA, The Lancet, and other global journals.
-
100+ Manuscripts & 1,000+ AbstractsOver 100+ manuscripts and 1,000+ abstracts authored by our experts.
Ready to Accelerate Your Clinical Program?
Partner with senior experts who deliver FDA- and EMA-ready data with efficiency and precision.
Meet Our Experts